» English
  • 診療について
  • 医局について
  • 医局員募集
  • 立峰会・ベイビーズ

研究グループ

循環器グループ

研究業績
  • Mito A, Hirono K, Ide H, Ozawa S, Ichida F, Taguchi M. Effects of concomitant administration of PXR ligand drugs on the anticoagulant effects of warfarin. Biol Pharm Bull. 2022 Apr in press.
  • Okabe M, Takarada S, Miyao N, Nakaoka H, Ibuki K, Ozawa S, Watanabe K, Tsuji H, Hashimoto I, Hatasaki K, Hayakawa S, Hamaguchi Y, Hamada M, Ichida F, Hirono K. G0S2 regulates innate immunity in Kawasaki disease via lncRNA HSD11B1-AS1. Pediatr Res. 2022 Mar in press.
  • Nii M, Inuzuka R, Inai K, Shimada E, Shinohara T, Kogiso T, Ono H, Ootsuki S, Kurita Y, Takeda A, Hirono K, Takei K, Yasukochi S, Yoshikawa T, Furutani Y, Shinozaki T, Matsuyama Y, Senzaki H, Tokushige K, Nakanishi T. Incidence and Expected Probability of Liver Cirrhosis and Hepatocellular Carcinoma After Fontan Operation. Circulation. 2021 Dec in press.
  • Mori H, Yoshikawa T, Kimura H, Ono H, Kato H, Ono Y, Nii M, Shindo T, Inuzuka R, Horigome H, Miura M, Hirono K, Kobayashi T, Kogaki S, Furutani Y, Nakanishi T. Outcomes of hypertrophic cardiomyopathy in Japanese children: a retrospective cohort study. Heart Vessels. 2021 Nov in press.
  • Aoki M, Ikeno Y, Ibuki K, Ozawa S, Hirono K, Yoshimura N. The mid-term outcome of interventricular septal hematoma after ventricular septal defect closure. Asian Cardiovasc Thorac Ann. 2021 Dec in press.
  • Inai K, Inuzuka R, Ono H, Nii M, Ohtsuki S, Kurita Y, Takeda A, Hirono K, Takei K, Yasukouchi S, Yoshikawa T, Furutani Y, Shimada E, Shinohara T, Shinozaki T, Matsuyama Y, Senzaki H, Nakanishi T. Predictors of long-term mortality among perioperative survivors of Fontan operation. Eur Heart J. 2021 Dec in press.
  • Hirono K, Takarada S, Okabe M, Miyao N, Nakaoka H, Ibuki K, Ozawa S, Origasa H, Ichida F, Imanaka-Yoshida K. Clinical significance of chronic myocarditis: systematic review and meta-analysis. Heart Vessels. 2022 Feb;37(2):300-314.
  • Gowda ST, Latson L, Sivakumar K, Hiremath G, Crystal M, Law M, Shahanavaz S, Asnes J, Veeram Reddy S, Kobayashi D, Alwi M, Ichida F, Hirono K, Tahara M, Takeda A, Minami T, Kutty S, Nugent AW, Forbes T, Prieto LR, Qureshi AM. Anatomical Classification and Posttreatment Remodeling Characteristics to Guide Management and Follow-Up of Neonates and Infants With Coronary Artery Fistula: A Multicenter Study From the Coronary Artery Fistula Registry. Circ Cardiovasc Interv. 2021 Dec;14(12):e009750.
  • Nakashima Y, Sakai Y, Mizuno Y, Furuno K, Hirono K, Takatsuki S, Suzuki H, Onouchi Y, Kobayashi T, Tanabe K, Hamase K, Miyamoto T, Aoyagi R, Arita M, Yamamura K, Tanaka T, Nishio H, Takada H, Ohga S, Hara T. Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease. Cardiovasc Res. 2021 Jan 1;117(1):96-108.
  • Oka H, Nakau K, Imanishi R, Furukawa T, Tanabe Y, Hirono K, Hata Y, Nishida N, Azuma H. A Case Report of a Rare Heterozygous Variant in the Desmin Gene Associated With Hypertrophic Cardiomyopathy and Complete Atrioventricular Block. CJC Open. 2021 May 12;3(9):1195-1198.
  • Yoshinaga M, Horigome H, Ayusawa M, Yasuda K, Kogaki S, Doi S, Tateno S, Ohta K, Hokosaki T, Nishihara E, Iwamoto M, Sumitomo N, Ushinohama H, Izumida N, Tauchi N, Kato Y, Kato T, Chisaka T, Higaki T, Yoneyama T, Abe K, Nozaki Y, Komori A, Kawai S, Ninomiya Y, Tanaka Y, Nuruki N, Sonoda M, Ueno K, Hazeki D, Nomura Y, Sato S, Hirono K, Hosokawa S, Takechi F, Ishikawa Y, Hata T, Ichida F, Ohno S, Makita N, Horie M, Matsushima S, Tsutsui H, Ogata H, Takahashi H, Nagashima M. Electrocardiographic Diagnosis of Hypertrophic Cardiomyopathy in the Pre- and Post-Diagnostic Phases in Children and Adolescents. Circ J. 2021 Dec 24;86(1):118-127.
  • Ozawa SW, Takarada S, Okabe M, Miyao N, Nakaoka H, Ibuki K, Ichida F, Hirono K; Fetal CM Study Collaborators. Clinical Characteristics and Prognosis of Fetal Left Ventricular Noncompaction in Japan. Circ J. 2021 Dec 24;86(1):98-105.
  • Nii M, Inuzuka R, Inai K, Shimada E, Shinohara T, Kogiso T, Ono H, Ootsuki S, Kurita Y, Takeda A, Hirono K, Takei K, Yasukochi S, Yoshikawa T, Furutani Y, Shinozaki T, Matsuyama Y, Senzaki H, Tokushige K, Nakanishi T. Incidence and Expected Probability of Liver Cirrhosis and Hepatocellular Carcinoma After Fontan Operation. Circulation. 2021 Dec 21;144(25):2043-2045.
  • Ichimata S, Hata Y, Hirono K, Yamaguchi Y, Nishida N. Clinicopathological features of clinically undiagnosed sporadic transthyretin cardiac amyloidosis: a forensic autopsy-based series. Amyloid. 2021 Jun;28(2):125-133.
  • Hirono K, Hata Y, Ozawa SW, Toda T, Momoi N, Fukuda Y, Inuzuka R, Nagamine H, Sakaguchi H, Kurosaki K, Okabe M, Takarada S, Miyao N, Nakaoka H, Ibuki K, Origasa H, Bowles NE, Nishida N, Ichida F; for LVNC study collaborators. A burden of sarcomere gene variants in fetal-onset patients with left ventricular noncompaction. Int J Cardiol. 2021 Apr 1328:122-129 .
  • Nakaoka H, Tsuda E, Morita Y, Kurosaki K. Cardiac Function by Magnetic Resonance Imaging in Coronary Artery Occlusions After Kawasaki Disease. Circ J. 2020 84(5):792-8.
  • Hirono K, Hata Y, Miyao N, Okabe M, Takarada S, Nakaoka H, Ibuki K, Ozawa S, Origasa H, Nishida N, Ichida F; LVNC study collaborates. Increased burden of ion channel gene variants is related to distinct phenotypes in pediatric patients with left ventricular noncompaction. Circ Genom Precis Med. 2020 Aug; 13(4): e002940.
  • Hirono K, Miyao N, Yoshinaga M, Nishihara E, Yasuda K, Tateno S, Ayusawa M, Sumitomo N, Horigome H, Iwamoto M, Takahashi H, Sato S, Kogaki S, Ohno S, Hata T, Hazeki D, Izumida N, Nagashima M, Ohta K, Tauchi N, Ushinohama H, Doi S, Ichida F; Study group on childhood cardiomyopathy in Japan. A significance of school screening electrocardiogram in the patients with ventricular noncompaction. Heart Vessels. 2020 Jul; 35(7): 985-95.
  • Hirono K, Hata Y, Miyao N, Okabe M, Takarada S, Nakaoka H, Ibuki K, Ozawa S, Yoshimura N, Nishida N, Ichida F, Lvnc Study Collaborators. Left ventricular noncompaction and congenital heart disease increases the risk of congestive heart failure. J Clin Med. 2020 Mar 13; 9(3). pii: E785.
  • Hirono K, Hata Y, Miyao N, Okabe M, Takarada S, Nakaoka H, Ibuki K, Ozawa S, Origasa H, Nishida N, Ichida F; LVNC study collaborates. Increased burden of ion channel gene variants is related to distinct phenotypes in pediatric patients with left ventricular noncompaction. Circ Genom Precis Med. 2020 Aug; 13(4): e002940.
  • Nakaoka H, Tsuda E, Morita Y, Kurosaki K. Cardiac Function by Magnetic Resonance Imaging in Coronary Artery Occlusions After Kawasaki Disease. Circ J. 2020 Apr 24;84(5):792-8.
  • Miyao N, Hata Y, Izumi H, Nagaoka R, Oku Y, Takasaki I, Ishikawa T, Takarada S, Okabe M, Nakaoka H, Ibuki K, Ozawa S, Yoshida T, Hasegawa H, Makita N, Nishida N, Mori H, Ichida F, Hirono K. TBX5 R264K acts as a modifier to develop dilated cardiomyopathy in mice independently of T-box pathway. PLoS One. 2020 Apr 1; 15(4): e0227393.
  • Hiraiwa A, Kawasaki Y, Ibuki K, Hirono K, Matsui M, Yoshimura N, Origasa H, Oishi K, Ichida F. Brain development of children with single ventricle physiology or transposition of the great arteries: A longitudinal observation study. Semin Thorac Cardiovasc Surg. 2020 Winter; 32(4):936-44.
  • Hiraiwa A, Ibuki K, Tanaka T, Hirono K, Miya K, Yoshimura N, Ichida F. Toddler neurodevelopmental outcomes are associated with School-Age IQ in children with single ventricle physiology. Semin Thorac Cardiovasc Surg. 2020 Summer; 32(2): 302-10.
  • Yoshida T, Hiraiwa A, Ibuki K, Makimoto M, Inomata S, Tamura K, Kawasaki Y, Ozawa S, Hirono K, Ichida F. Neurodevelopmental outcomes at three years for infants with CHD and VLBW. Pediatr Int. 2020 Jul; 62(7): 797-803.
  • Ishikawa T, Mishima H, Barc J, Takahashi MP, Hirono K, Terada S, Kowase S, Sato T, Mukai Y, Yui Y, Ohkubo K, Kimoto H, Watanabe H, Hata Y, Aiba T, Ohno S, Chishaki A, Shimizu W, Horie M, Ichida F, Nogami A, Yoshiura KI, Schott JJ, Makita N. Cardiac Emerinopathy: A non-syndromic nuclear envelopathy with increased risk of thromboembolic stroke due to progressive atrial standstill and left ventricular non-compaction. Circ Arrhythm Electrophysiol. 2020 Oct; 13(10): e008712.
  • Takeuchi M, Kobayashi T, Biss T, Kamali F, Vear SI, Ho RH, Bajolle F, Loriot MA, Shaw K, Carleton BC, Hamberg AK, Wadelius M, Hirono K, Taguchi M, Wakamiya T, Yanagimachi M, Hirai K, Itoh K, Brandão LR, Ito S. CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis. Pharmacogenomics J. 2020 Apr; 20(2): 306-319.
  • Kanai T, Takeshita S, Kawamura Y, Kinoshita K, Nakatani K, Iwashima S, Takizawa Y, Hirono K, Mori K, Yoshida Y, Nonoyama S. The Combination of the Neutrophil-To-Lymphocyte and Platelet-To-Lymphocyte Ratios as a Novel Predictor of Intravenous Immunoglobulin Resistance in Patients With Kawasaki Disease: A Multicenter Study. Heart Vessels. 2020 Oct; 35(10): 1463-72.
  • Armaroli G, Verweyen E, Pretzer C, Kessel K, Hirono K, Ichida F, Okabe M, Cabral DA, Foell D, Brown KL, Kessel C. S100A12-induced sterile inflammatory activation of human coronary artery endothelial cells is driven by monocyte-derived interleukin 1β: implications for Kawasaki disease pathology. Arthritis Rheumatol. 2019 May; 71(5):792-804.
  • Tamura R, Watanabe N, Nakamura S, Yoshimura N, Ozawa S, Hirono K, Ichida F, Taguchi M. Evaluation of the effects of ontogenetic or maturation functions and chronic heart failure on the model analysis for the dose-response relationship of warfarin in Japanese children. Eur J Clin Pharmacol. 2019 Jul; 75(7):913-20.
  • Shigetomi N, Kamiya K, Takamori T, Yoshimura N, Ozawa S, Hirono K, Ichida F, Taguchi M. Determination of the serum unbound fraction of Tadalafil in children with protein-losing enteropathy and its specific binding to human serum proteins in Vitro. Biol Pharm Bull. 2019; 42(1): 110-5.
  • Hirono K, Hata Y, Nakazawa M, Momoi N, Tsuji T, Matsuoka T, Ayusawa M, Abe Y, Hayashi T, Tsujii N, Abe T, Sakaguchi H, Wang C, Takasaki A, Takarada S, Okabe M, Miyao N, Nakaoka H, Ibuki K, Saito K, Ozawa S, Nishida N, Bowles NE, Ichida F. Clinical and Echocardiographic Impact of Tafazzin Variants on Dilated Cardiomyopathy Phenotype in Left Ventricular Non-Compaction Patients in Early Infancy. Circ 2018 Sep 25; 82(10): 2609-18.
  • Takasaki A, Hirono K, Hata Y, Wang C, Takeda M, Yamashita JK, Chang B, Nakaoka H, Okabe M, Miyao N, Saito K, Ibuki K, Ozawa S, Sekine M, Yoshimura N, Nishida N, Bowles NE, Ichida F. Sarcomere gene variants act as a genetic trigger underlying the development of left ventricular noncompaction. Pediatr Res. 2018 Nov; 84(5): 733-42.
  • Nakaoka H, Hirono K, Yamamoto S, Takasaki I, Takahashi K, Kinoshita K, Takasaki A, Nishida N, Okabe M, Ce W, Miyao N, Saito K, Ibuki K, Ozawa S, Adachi Y, Ichida F. MicroRNA-145-5p and microRNA-320a encapsulated in endothelial microparticles contribute to the progression of vasculitis in acute Kawasaki Disease. Sci Rep. 2018 Jan 17; 8(1): 1016.
  • Wang C, Hata Y, Hirono K, Takasaki A, Ozawa SW, Nakaoka H, Saito K, Miyao N, Okabe M, Ibuki K, Nishida N, Origasa H, Yu X, Bowles NE, Ichida F; for LVNC Study Collaborators. A Wide and Specific Spectrum of Genetic Variants and Genotype-Phenotype Correlations Revealed by Next-Generation Sequencing in Patients with Left Ventricular Noncompaction. J Am Heart Assoc. 2017 Aug 30; 6(9).
  • Wang C, Takasaki A, Ozawa S, Nakaoka H, Okabe M, Miyao N, Saito K, Ibuki K, Hirono K, YoshimuraN, Yu X, IchidaF. Long-term prognosis of patients with Left Ventricular Noncompaction: A Comparison between Infantile and Juvenile Types. Circ J. 2017 Apr 25;81(5):694-700.
  • Yamaguchi Y, Mizumaki K, Hata Y, Sakamoto T, Nakatani Y, Kataoka N, Ichida F, Inoue H, Nishida N. Latent pathogenicity of the G38S polymorphism of KCNE1 K+ channel modulator. Heart Vessels. 2017 Feb;32(2):186-192.
  • Yoshida Y, Hirono K, Nakamura K, Suzuki T, Hata Y, Nishida N. A novel ACTC1 gene mutation in a young boy with left ventricular noncompaction and arrhythmias. Heart Rhythm Case Report　2016 2: 92–97.
  • Gaynor JW, Stopp C, Ichida F, et al. Impact of operative and postoperative factors on neurodevelopmental outcomes after cardiac operations. Ann Thorac Surg. 2016 Sep;102(3):843-9.
  • Kobayashi T, Fuse S, Sakamoto N, Mikami M, Ogawa S, Hamaoka K, Arakaki Y, Nakamura T, Nagasawa H, Kato T, Jibiki T, Iwashima S, Yamakawa M, Ohkubo T, Shimoyama S, Aso K, Sato S, Saji T; Z Score Project Investigators. A new Z score curve of the coronary arterial internal diameter using the lambda-mu-sigma method in a pediatric population. J Am Soc Echocardiogr. 2016 Aug;29(8):794-801.e29.
  • Okuma Y, Suda K, Nakaoka H, Katsube Y, Mitani Y, Yoshikane Y, Ichida F, et al. Serum Tenascin-C as a Novel Predictor for Risk of Coronary Artery Lesion and Resistance to Intravenous Immunoglobulin in Kawasaki Disease　- A Multicenter Retrospective Study. Circ J. 2016 Oct 25;80(11):2376-2381.
  • Matsuura H, Ichida F, et al. Clinical features of acute and fulminant myocarditis in children　- 2nd nationwide survey by Japanese society of pediatric cardiology and cardiac surgery. Circ J. 2016 Oct 25;80(11):2362-2368.
  • Kodo K, Ong SG, Jahanbani F, Ichida F, et al. iPSC-derived cardiomyocytes reveal abnormal TGF-β signalling in left ventricular non-compaction cardiomyopathy. Nat Cell Biol. 2016 Oct; 18(10): 1031-42.
  • Saito K, Nakaoka H, Takasaki I, Hirono K, Yamamoto S, Kinoshita K, Miyao N, Ibuki K, Ozawa S, Watanabe K, Bowles NE, Ichida F. MicroRNA-93 may control vascular endothelial growth factor A in circulating peripheral blood mononuclear cells in acute Kawasaki disease. Pediatr Res. 2016 Sep;80(3):425-32.
  • Hachiya A, Motoki N, Akazawa Y, Matsuzaki S, Hirono K, Hata Y, Nishida N, Ichida F, Koike K. Left ventricular non-compaction revealed by aortic regurgitation due to Kawasaki disease in a boy with LDB3 mutation. Pediatr Int. 2016 Aug;58(8):797-800.
  • Hirono K, Hata Y, Miyao N, Nakaoka H, Saito K, Ibuki K, Watanabe K, Ozawa S, Higuma T, Yoshimura N, Nishida N, Ichida F. Anomalous origin of the right coronary artery evaluated with multidetector computed tomography and its clinical relevance. J Cardiol. 2016 Sep;68(3):196-201.
  • Nakamura S, Watanabe N, Yoshimura N, Ozawa S, Hirono K, Ichida F, Taguchi M. A model analysis for dose-response relationship of warfarin in Japanese children: An introduction of the SIZE parameter. Drug Metab Pharmacokinet. 2016 Jun;31(3):234-41.
  • Miyazaki A, Oguri A, Ichida F. Non-high-density lipoprotein cholesterol as a cardiovascular risk screening tool in children. Pediatr Int. 2016 Jun;58(6):439-44.
  • Hata Y, Kinoshita K, Mizumaki K, Yamaguchi Y, Hirono K, Ichida F, Takasaki A, Mori H, Nishida N. Postmortem genetic analysis of sudden unexplained death syndrome under 50 years of age: A next-generation sequencing study. Heart Rhythm. 2016 Jul;13(7):1544-51.
  • Ochiai R, Kato H, Akiyama N, Ichida F, Yao A, Inuzuka R, Niwa K, Shiraishi I, Nakanishi T. Nationwide survey of the transfer of adults with congenital heart disease from pediatric cardiology departments to adult congenital heart disease centers in Japan. Circ J. 2016 Apr 25;80(5):1242-50.
  • Hashimoto I, Watanabe K, Ichida F. Right to Left Ventricular Diameter Ratio ≥0.42 is the Warning Flag for Suspecting Atrial Septal Defect in Preschool Children: Age- and Body Surface Area-Related Reference Values Determined by M-Mode Echocardiography. Pediatr Cardiol. Apr;37(4):704-13.
  • Hirono K, Ichida F. Utility of TNF-α as a biomarker and the possibility of anti-TNF-α therapy for Kawasaki Diseases. Pediat Therapeut 2015; 5: 257.
  • Hashimoto I, Watanabe K, Okabe M, Kaneda H. Impairment of left ventricular longitudinal contraction is associated with serum brain natriuretic peptide concentration in patients with acute-phase Kawasaki Disease. Pediatr Cardiol. 2015 Jun;36(5):979-86.
  • Iwaki R, Higuma T, Ichida F, Yoshimura N. Follow-Up of Persistent Tracheal Stenosis After Surgery for a Double Aortic Arch. World J Pediatr Congenit Heart Surg. 2015 Jul;6(3):458-61.
  • Watanabe K, Hashimoto I, Ibuki K, Okabe M, Kaneda H, Ichida F. Evaluation of Right Ventricular Function Using Single-Beat Three-Dimensional Echocardiography in Neonate. Pediatr Cardiol. 2015 Jun;36(5):918-24.
  • Gaynor JW, Stopp C, Wypij D, Andropoulos DB, Atallah J, Atz AM, Beca J, Donofrio MT, Duncan K, Ghanayem NS, Goldberg CS, Hövels-Gürich H, Ichida F, Jacobs JP, Justo R, Latal B, Li JS, Mahle WT, McQuillen PS, Menon SC, Pemberton VL, Pike NA, Pizarro C, Shekerdemian LS, Synnes A, Williams I, Bellinger DC, Newburger JW; International Cardiac Collaborative on Neurodevelopment (ICCON) Investigators. Neurodevelopmental outcomes after cardiac surgery in infancy. Pediatrics. 2015 May;135(5):816-25.
  • Takahiro R, Nakamura S, Kohno H, Yoshimura N, Nakamura T, Ozawa S, Hirono K, Ichida F, Taguchi M. Contribution of CYP3A Isoforms to Dealkylation of PDE5 Inhibitors: A Comparison between Sildenafil N-Demethylation and Tadalafil Demethylenation. Biol Pharm Bull. 2015;38(1):58-65.
  • Nomura Y, Momoi N, Hirono K, Hata Y, Takasaki A, Nishida N, Ichida F. A novel MYH7 gene mutation in a fetus with left ventricular noncompaction. Can J Cardiol. 2015 Jan;31(1):103.e1-3.
  • Hirono K, Hata Y, Nakaoka H, Ibuki K, Ozawa S, Yoshida T, Aoki M, Higuma T, Yoshimura N, Nishida N, Ichida F. Familial Ebstein Anomaly, Left Ventricular Noncompaction, and Ventricular Septal Defect Associated With a MYH7 Mutation. J Thorac Cardiovasc Surg. 2014 Nov;148(5):e223-6.
  • Hirono K, Ibuki K, Tomita H. Percutaneous catheter aspiration thrombectomy for the occluded stents of pulmonary artery in children with single ventricle physiology after fontan surgery. Catheter Cardiovasc Interv. 2014 Dec 1;84(7):1153-6.
  • Ichida F. Cardiovascular Events in Pregnancy With Hypertrophic Cardiomyopathy. Circ J. 2014 Sep 25;78(10):2386-7.
  • Kohno H, Ichida F, Hirono K, Ozawa S, Yoshimura N, Nakamura T, Akita C, Ishida K, Taguchi M. Plasma Concentrations of Tadalafil in Children With Pulmonary Arterial Hypertension. Ther Drug Monit. 2014 Oct;36(5):576-83.
  • Kinoshita K, Komatsu T, Nishide K, Hata Y, Hisajima N, Takahashi H, Kimoto K, Aonuma K, Tsushima E, Tabata T, Yoshida T, Mori H, Nishida K, Yamaguchi Y, Ichida F, Fukurotani K, Inoue H, Nishida N. A590T mutation in KCNQ1 C-terminal helix D decreases IKs channel trafficking and function but not Yotiao interaction. J Mol Cell Cardiol. 2014 Jul;72:273-80.
  • Tabata T, Yamaguchi Y, Hata Y, Ichida F, Mori H. Modification of KCNH2-Encoded cardiac potassium channels by KCNE1 polymorphism. Circ J. 2014 Aug 25;78(9):2331.
  • Bowles NE, Arrington CB, Hirono K, Nakamura T, Ngo L, Wee YS, Ichida F, Weis JH. Kawasaki disease patients homozygous for the rs12252-C variant of interferon-induced transmembrane protein-3 are significantly more likely to develop coronary artery lesions. Mol Genet Genomic Med. 2014 Jul;2(4):356-61.
  • Hata Y, Kinoshita K, Miya K, Hirono K, Ichida F, Yoshida K, Nishida N. An autopsy case of infantile-onset vanishing white matter disease related to an EIF2B2 mutation (V85E) in a hemizygous region. Int J Clin Exp Pathol. 2014 May 15;7(6):3355-62.
  • Horie A, Ishida K, Shibata K, Taguchi M, Ozawa A, Hirono K, Ichida F, Hashimoto Y. Pharmacokinetic variability of flecainide in younger Japanese patients and mechanisms for renal excretion and intestinal absorption. Biopharm Drug Dispos. Apr;35(3):145-53.
  • Hirono K, Sekine M, Shiba N, Hayashi S, Nakaoka H, Ibuki K, Saito K, Watanabe K, Ozawa S, Higuma T, Yoshimura N, Kitajima I, Ichida F. N-terminal pro-brain natriuretic peptide as a predictor of reoperation in children with surgically corrected tetralogy of Fallot. Circ J. 2014 Feb 25;78(3):693-700.
  • Yamaguchi Y, Nishide K, Kato M, Hata Y, Mizumaki K, Kinoshita K, Nonobe Y, Tabata T, Sakamoto T, Kataoka N, Nakatani Y, Ichida F, Mori H, Fukurotani K, Inoue H, Nishida N. Glycine/Serine Polymorphism at Position 38 Influences KCNE1 Subunit's Modulatory Actions on Rapid and Slow Delayed Rectifier K+ Currents. Circ J. 2014 Feb 25;78(3):610-8.
  • Mitani Y, Ohta K, Ichida F, Nii M, Arakaki Y, Ushinohama H, Takahashi T, Ohashi H, Yodoya N, Fujii E, Ishikura K, Tateno S, Sato S, Suzuki T, Higaki T, Iwamoto M, Yoshinaga M, Nagashima M, Sumitomo N. Circumstances and Outcomes of Out-Of-Hospital Cardiac Arrest in Elementary and Middle School Students in the Era of Public-Access Defibrillation. Circ J. 2014 Feb 25;78(3):701-7.
  • Hata Y, Mori H, Tanaka A, Fujita Y, Shimomura T, Tabata T, Kinoshita K, Yamaguchi Y, Ichida F, Kominato Y, Ikeda N, Nishida N. Identification and characterization of a novel genetic mutation with prolonged QT syndrome in an unexplained postoperative death. Int J Legal Med. 2014 Jan;128(1):105-15.
  • Matsuhisa H, Yoshimura N, Higuma T, Misaki T, Onuma Y, Ichida F, Oshima Y, Okita Y. Ventricular septal dysfunction after surgical closure of multiple ventricular septal defects. Ann Thorac Surg. 96: 891-897, 2013.
  • Chang B, Gorbea C, Lezin G, Shan L, Sakai N, Kogaki S, Otomo T, Okinaga T, Hamaoka A, Yu X, Hata Y, Nishida N, Yost HJ, Bowles NE, Brunelli L, Ichida F. 14-3-3ε Gene Variants in a Japanese Patient with Left Ventricular Noncompaction and Hypoplasia of the Corpus Callosum. Gene. 515:173-80, 2013.
  • Sakazaki H, Niwa K, Nakazawa M, Saji T, Nakanishi T, Takamuro M, Ueno M, Kato H, Takatsuki S, Matsushima M, Kojima N, Ichida F, et al. Clinical features of adult patients with Eisenmenger's syndrome in Japan and Korea. Int J Cardiol. 167: 205-209, 2013.
  • Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, Kato T, Hara T, Hamaoka K, Ogawa S, Miura M, Nomura Y, Fuse S, Ichida F, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE): a randomised, open-label, blinded-endpoints trial. Lancet 379:1613-1620, 2012.
  • Ibuki K, Watanabe K, Yoshimura N, Kakimoto T, Matsui M, Yoshida T, Origasa H, Ichida F. The improvement of hypoxia correlates with neuroanatomical and developmental outcomes; Comparison of mid-term outcomes in infants with TGA or Single Ventricle physiology. J Thorac Cardiovasc Surg. 143:1077-1085, 2012.
  • Otsuka H, Arimura T, Abe T, Kawai H, Aizawa Y, Kubo T, Kitaoka H, Nakamura H, Nakamura K, Okamoto H, Ichida F, Ayusawa M, Nunoda S, Isobe M, Matsuzaki M, Doi YL, Fukuda K, Sasaoka T, Izumi T, Ashizawa N, Kimura A. Prevalence and Distribution of Sarcomeric Gene Mutations in Japanese Patients With Familial Hypertrophic Cardiomyopathy. Circ J. 2012:453-61
  • Chida A, Shintani M, Yagi H, Fujiwara M, Kojima Y, Sato H, Imamura S, Yokozawa M, Onodera N, Horigome H, Kobayashi T, Hatai Y, Nakayama T, Fukushima H, Nishiyama M, Doi S, Ono Y, Yasukouchi S, Ichida F, et al. Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers. Am J Cardiol. 110: 586-593, 2012.
  • Chang B, Nishizawa T, Furutani M, Fujiki A, Tani M, Kawaguchi M, Ibuki K, Hirono K, Taneichi H, Uese K, Onuma Y, Bowles NE, Ichida F, Inoue H, Matsuoka R, Miyawaki T. Identification of a novel TPM1 mutation in a family with left ventricular noncompaction and sudden death. Mol Genet Metab. 102:200-206, 2011.
  • Hirono K, Yoshimura N, Taguchi M, Watanabe K, Nakamura T, Ichida F, Miyawaki T. Bosentan induces clinical and hemodynamic improvement in candidates for right-sided heart bypass surgery. J Thorac Cardiovasc Surg. 140: 346-351, 2010.
  • Chang B, Momoi N, Shan L, Mitomo M, Aoyagi Y, Endo K, Takeda I, Chen R, Xing Y, Yu X, Watanabe S, Yoshida T, Kanegane H, Tsubata S, Bowles NE, Ichida F, Miyawaki T. Noncompaction study collaborators. Gonadal mosaicism of a TAZ (G4.5) mutation in a Japanese family with Barth syndrome and left ventricular noncompaction. Mol Genet Metab. 100:198-203, 2010.
  • Watanabe S, Hashimoto I, Saito K, Watanabe K, Hirono K, Uese K, Ichida F, Saito S, Miyawaki T, et al. Characterization of ventricular myocardial performance in the fetus by tissue doppler imaging. Circ J. 73: 943-947, 2009.
  • Saito K, Ibuki K, Yoshimura N, Hirono K, Watanabe S, Watanabe K, Uese K, Yasukouchi S, Ichida F, Miyawaki T. Successful cardiac resynchronization therapy in a 3-year-old girl eith isolated left ventricular non-compaction and narrow QRS complex -A case report - Circ J. 73: 2173-2177, 2009.
  • Hirono K, Saito K, Watanbe S, Ibuki K, Kanegane H, Kennmochi Y, Wittkowski H, Foell D, Roth J, Ichida F,et al. The efficacy of infliximab treatment and dynamic changes of inflammatory cytokines in patients with refractory Kawasaki disease. Peditaric Res. 65: 696-701, 2009.
  • Watanabe K, Matsui M, Matsuzawa J, Noguchi K, Yoshimura N, Oshima Y, Tanaka C, Hongo K, Ichida F,et al. Evaluation of neuroanatomical development of the infants after heart surgery using 3D-MRI volumetry of the brain. J Thorac Cardiov Surg. 137: 146-153, 2009.
  • Dougu N, Joho S, Shan L, Shida T, Matsuki A, Uese K, Hirono K, Ichida F, et al. Novel LAMP-2 Mutation in a Family with Danon Disease Presenting With Hypertrophic Cardiomyopathy. Circ J. 73:376-380, 2009.
  • Ichida F. Left ventricular noncompaction. Circ J. 73: 19-26, 2009.
  • Shan L, Makita N, Xing Y, Watanabe S, Futatani T, Ye F, Saito K, Ibuki K, Watanabe K, Hirono K, Uese K, Ichida F, et al. SCN5A variants in Japanese patients with left ventricular noncompaction and arrhythmia. Mol Genet Metab. 93: 468-474, 2008.
  • Wittkowski H, Hirono K, Ichida F, et al. Reverse kinetics of circulating soluble receptor for advanced glycation end products (sRAGE) and its ligand S100A12 in acute Kawasaki disease. Arthritis and Rheumatism 56: 4174-4181, 2007.
  • Xing Y, Chen R, Ichida F, et al. Genetic Analysis in Patients with Left Ventricular Noncompaction and Evidence for Genetic Heterogeneity. Mol Genet Metab. 88: 71-77, 2006.
  • Hirono K, Foell D, Xing Y, Ichida F, Roth J, et al. Expression of myeloid related protein (MRP) 8 and MRP14 in acute Kawasaki disease. J Am Coll Cardiol. 48: 1257-1264, 2006.
  • Viemann D, Strey A, Janning A, Jurk K, Klimmek K, Vogl T, Hirono K, Ichida F, et al. Myeloid-related protein 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 105: 2955-2962, 2005.
  • Ye F, Foell D, Hirono K, Vogl T, Rui C, Yu X, Watanabe S, Watanabe K, Uese K, Hashimoto I, Ichida F, Miyawaki T. Profound S100A12 expression in early stage of Acute Kawasaki Disease. Am J Cardiol. 94: 840-844, 2004.
  • Yu X, Hirono K, Ichida F, et al. Enhanced iNOS expression in leukocytes and circulating endothelial cells is associated with the progression of coronary artery lesions in acute Kawasaki disease. Pediatr Res. 55: 688-694, 2004.
  • Yagi H, Furutani Y, Hamada H, Asakawa S, Minoshima S, Ichida F, et al. TBX1 is a major genetic determinant of human del22q11.2 syndrome. Lancet 362: 1366-1373, 2003.
  • Foell D, Ichida F, Vogl T, et al. S100A12 (EN-RAGE) in monitering Kawasaki disease. Lancet 361:1270-1272, 2003.
  • Chen R, Tsuji T, Ichida F, et al. Mutation analysis of the G4.5 gene in patients with isolated left ventricular noncompaction. Mol Genet Metab. 77: 319-325, 2002.
  • Ichida F, Tsubata S, Bowles KR, et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation 103: 1256-1263, 2001.
  • Hamamichi Y, Ichida F, Xianyi Y, et al. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease. Pediatr Res. 49: 74-80, 2001.
  • Tsubata S, Bowles KR, Vatta M, et al. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest. 106: 655-662, 2000.
  • Ichida F, Hamamichi Y, Miyawaki T, et al. Clinical features of isolated noncompaction of the ventricular myocardium: Long-term clinical course, hemodynamic properties, and genetic background. J Am Coll Cardiol. 34: 233-240, 1999.
  • Hashimoto I, Ichida F, Miura M, et al. Automatic border detection identifies asymptomatic anthracycline cardiotoxicity in children with malignancy. Circulation 99: 2367-2370, 1999.

pagetop